In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome

Metabolic syndrome is a significant worldwide public health challenge and is inextricably linked to adverse renal and cardiovascular outcomes. The inhibition of the transient receptor potential cation channel subfamily C member 6 (TRPC6) has been found to ameliorate renal outcomes in the unilateral...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhihuang, Xu, Yao, Krügel, Ute, Schaefer, Michael, Grune, Tilman, Nürnberg, Bernd, Köhler, May-Britt, Gollasch, Maik, Tsvetkov, Dmitry, Markó, Lajos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224794/
https://www.ncbi.nlm.nih.gov/pubmed/35743312
http://dx.doi.org/10.3390/ijms23126870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224794/
https://www.ncbi.nlm.nih.gov/pubmed/35743312
http://dx.doi.org/10.3390/ijms23126870

Ejemplares similares